Efficacy and safety of camrelizumab plus docetaxel and carboplatin as…
An anthracycline-free immunotherapy combination shows promise for triple-negative breast cancer, offering an alternative approach to current treatment standards.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Navigating the landscape of targeted therapies for renal cell…
Emerging biomarkers help doctors better match kidney cancer patients with targeted therapies most likely to work for their specific tumors.
Standard additionChios Mastic in Well-Controlled Hypertension
A natural mastic supplement shows measurable vascular benefits in people with harder-to-control high blood pressure, warranting study in higher-risk groups.
Standard additionExternal Validation of the CARE-BMT and Modified CARE-BMT Scores for…
A refined heart disease risk tool for transplant patients now includes transplant-specific factors, improving prediction accuracy after bone marrow transplant.
Standard additionRobustness of Nomogram Versus Deep Learning Models for Hepatocarcinoma Grading
Simple statistical models for liver cancer grading prove more reliable across different hospitals than complex AI systems that lose accuracy outside their training data.